The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients
Authors:
Open Access
- 15 February 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-11
Abstract
Protein-bound uremic toxins (Indoxyl sulfate [IS] and p-cresyl sulfate [PCS]) are both associated with cardiovascular (CV) and all-cause mortality in subjects with chronic kidney disease (CKD). Possible mechanisms have not been elucidated. In hemodialysis patients, we investigated the relationship between the free form of IS and PCS and 181 CV-related proteins. First, IS or PCS concentrations were checked, and high levels were associated with an increased risk of acute coronary syndrome (ACS) in 333 stable HD patients. CV proteins were further quantified by a proximity extension assay. We examined associations between the free form protein-bound uremic toxins and the quantified proteins with correction for multiple testing in the discovery process. In the second step, the independent association was evaluated by multivariable-adjusted models. We rank the CV proteins related to protein-bound uremic toxins by bootstrapped confidence intervals and ascending p-value. Six proteins (signaling lymphocytic activation molecule family member 5, complement component C1q receptor, C–C motif chemokine 15 [CCL15], bleomycin hydrolase, perlecan, and cluster of differentiation 166 antigen) were negatively associated with IS. Fibroblast growth factor 23 [FGF23] was the only CV protein positively associated with IS. Three proteins (complement component C1q receptor, CCL15, and interleukin-1 receptor-like 2) were negatively associated with PCS. Similar findings were obtained after adjusting for classical CV risk factors. However, only higher levels of FGF23 was related to increased risk of ACS. In conclusion, IS and PCS were associated with several CV-related proteins involved in endothelial barrier function, complement system, cell adhesion, phosphate homeostasis, and inflammation. Multiplex proteomics seems to be a promising way to discover novel pathophysiology of the uremic toxin.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 105-2628-B-037-005-MY2, MOST 107-2314-B-037-021-MY2)
- Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH105-5R15, KMUH106-6R16)
- Kaohsiung Medical University (KMU-TP104PR24)
This publication has 53 references indexed in Scilit:
- Cardiovascular Burden Associated with Uremic Toxins in Patients with Chronic Kidney DiseaseAmerican Journal of Nephrology, 2013
- Psoriasiform dermatitis is driven by IL-36–mediated DC-keratinocyte crosstalkJournal of Clinical Investigation, 2012
- Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylationKidney International, 2012
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney DiseaseJAMA, 2011
- Plasma CD93 concentration is a potential novel biomarker for coronary artery diseaseJournal of Internal Medicine, 2011
- p-Cresol and Cardiovascular Risk in Mild-to-Moderate Kidney DiseaseClinical Journal of the American Society of Nephrology, 2010
- Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease PatientsClinical Journal of the American Society of Nephrology, 2009
- Homocysteine as a Risk Factor for Cardiovascular Disease in Patients Treated by Dialysis: A Meta–analysisAmerican Journal of Kidney Diseases, 2009
- Chemokine Lkn-1/CCL15 enhances matrix metalloproteinase-9 release from human macrophages and macrophage-derived foam cellsNutrition Research and Practice, 2008
- Increase of expression and activation of chemokine CCL15 in chronic renal failureBiochemical and Biophysical Research Communications, 2006